158 related articles for article (PubMed ID: 15577424)
1. Magnitude and determinants of first-time and repeat testing among individuals with newly diagnosed HIV infection between 2000 and 2001 in Alberta, Canada: results from population-based laboratory surveillance.
Jayaraman GC; Bush KR; Lee B; Singh AE; Preiksaitis JK
J Acquir Immune Defic Syndr; 2004 Dec; 37(5):1651-6. PubMed ID: 15577424
[TBL] [Abstract][Full Text] [Related]
2. Trends in testing behaviours for hepatitis C virus infection and associated determinants: results from population-based laboratory surveillance in Alberta, Canada (1998-2001).
Jayaraman GC; Lee B; Singh AE; Preiksaitis JK
J Viral Hepat; 2007 Apr; 14(4):249-54. PubMed ID: 17381716
[TBL] [Abstract][Full Text] [Related]
3. Seroprevalence survey of Egyptian tourism workers for hepatitis B virus, hepatitis C virus, human immunodeficiency virus, and Treponema pallidum infections: association of hepatitis C virus infections with specific regions of Egypt.
el-Sayed NM; Gomatos PJ; Rodier GR; Wierzba TF; Darwish A; Khashaba S; Arthur RR
Am J Trop Med Hyg; 1996 Aug; 55(2):179-84. PubMed ID: 8780457
[TBL] [Abstract][Full Text] [Related]
4. Twin epidemics of new and prevalent hepatitis C infections in Canada: BC Hepatitis Testers Cohort.
Janjua NZ; Yu A; Kuo M; Alvarez M; Cook D; Wong J; Tyndall MW; Krajden M
BMC Infect Dis; 2016 Jul; 16():334. PubMed ID: 27436414
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of hepatitis B and C seropositivity in a Nigerian cohort of HIV-infected patients.
Otegbayo JA; Taiwo BO; Akingbola TS; Odaibo GN; Adedapo KS; Penugonda S; Adewole IF; Olaleye DO; Murphy R; Kanki P
Ann Hepatol; 2008; 7(2):152-6. PubMed ID: 18626434
[TBL] [Abstract][Full Text] [Related]
6. Differing profiles of people diagnosed with acute and chronic hepatitis B virus infection in British Columbia, Canada.
Binka M; Butt ZA; Wong S; Chong M; Buxton JA; Chapinal N; Yu A; Alvarez M; Darvishian M; Wong J; McGowan G; Torban M; Gilbert M; Tyndall M; Krajden M; Janjua NZ
World J Gastroenterol; 2018 Mar; 24(11):1216-1227. PubMed ID: 29568202
[TBL] [Abstract][Full Text] [Related]
7. Hepatitis C virus and human immunodeficiency virus coinfection among attendants of voluntary counseling and testing centre and HIV follow up clinics in Mekelle Hospital.
Hadush H; Gebre-Selassie S; Mihret A
Pan Afr Med J; 2013; 14():107. PubMed ID: 23717721
[TBL] [Abstract][Full Text] [Related]
8. Sero-prevalence of hepatitis B and C viral infections in Ghanaian HIV positive cohort: a consideration for their health care.
Pappoe F; Hagan CKO; Obiri-Yeboah D; Nsiah P
BMC Infect Dis; 2019 May; 19(1):380. PubMed ID: 31053100
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of serologic markers of HBV, HDV, HCV and HIV in non-injection drug users compared to injection drug users in Gran Canaria, Spain.
Santana Rodríguez OE; Malé Gil ML; HernándezSantana JF; Limiñana Cañal JM; Martín Sánchez AM
Eur J Epidemiol; 1998 Sep; 14(6):555-61. PubMed ID: 9794122
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of hepatitis C and hepatitis B infection in the HIV-infected population of France, 2004.
Larsen C; Pialoux G; Salmon D; Antona D; Le Strat Y; Piroth L; Pol S; Rosenthal E; Neau D; Semaille C; Delarocque Astagneau E
Euro Surveill; 2008 May; 13(22):. PubMed ID: 18761958
[TBL] [Abstract][Full Text] [Related]
11. Risk behaviors and HIV incidence among repeat testers at publicly funded HIV testing sites in San Francisco.
Fernyak SE; Page-Shafer K; Kellogg TA; McFarland W; Katz MH
J Acquir Immune Defic Syndr; 2002 Sep; 31(1):63-70. PubMed ID: 12352152
[TBL] [Abstract][Full Text] [Related]
12. Screening for HIV, HBV and HCV markers among drug users in treatment in rural south-east England.
Edeh J; Spalding P
J Public Health Med; 2000 Dec; 22(4):531-9. PubMed ID: 11192282
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of hepatitis B virus and hepatitis C virus co-infection with human immunodeficiency virus in Thai patients: a tertiary-care-based study.
Sungkanuparph S; Vibhagool A; Manosuthi W; Kiertiburanakul S; Atamasirikul K; Aumkhyan A; Thakkinstian A
J Med Assoc Thai; 2004 Nov; 87(11):1349-54. PubMed ID: 15825712
[TBL] [Abstract][Full Text] [Related]
14. Seroprevalence and risk factors of hepatitis B, hepatitis C, and human cytomegalovirus among HIV-infected and high-risk uninfected adolescents: findings of the REACH Study. Adolescent Medicine HIV/AIDS Research Network.
Holland CA; Ma Y; Moscicki B; Durako SJ; Levin L; Wilson CM
Sex Transm Dis; 2000 May; 27(5):296-303. PubMed ID: 10821605
[TBL] [Abstract][Full Text] [Related]
15. Clinical characteristics of hepatitis B and C virus infections in HIV-infected patients.
Phuangchoei P; Chotiyaputta W; Chayakulkeeree M
J Med Assoc Thai; 2015 Mar; 98(3):226-31. PubMed ID: 25920291
[TBL] [Abstract][Full Text] [Related]
16. HIV, Hepatitis B and C among people who inject drugs: high prevalence of HIV and Hepatitis C RNA positive infections observed in Delhi, India.
Ray Saraswati L; Sarna A; Sebastian MP; Sharma V; Madan I; Thior I; Pulerwitz J; Tun W
BMC Public Health; 2015 Jul; 15():726. PubMed ID: 26223866
[TBL] [Abstract][Full Text] [Related]
17. Human immunonodeficiency virus, hepatitis B virus and hepatitis C virus: sero-prevalence, co-infection and risk factors among prison inmates in Nasarawa State, Nigeria.
Adoga MP; Banwat EB; Forbi JC; Nimzing L; Pam CR; Gyar SD; Agabi YA; Agwale SM
J Infect Dev Ctries; 2009 Aug; 3(7):539-47. PubMed ID: 19762972
[TBL] [Abstract][Full Text] [Related]
18. Prevalence and behavioural risks for HIV and HCV infections in a population of drug users of Dakar, Senegal: the ANRS 12243 UDSEN study.
Leprêtre A; Ba I; Lacombe K; Maynart M; Toufik A; Ndiaye O; Kane CT; Gozlan J; Tine J; Ndoye I; Raguin G; Girard PM
J Int AIDS Soc; 2015; 18(1):19888. PubMed ID: 26004637
[TBL] [Abstract][Full Text] [Related]
19. Repeat HIV testing: high-risk behaviour or risk reduction strategy?
Leaity S; Sherr L; Wells H; Evans A; Miller R; Johnson M; Elford J
AIDS; 2000 Mar; 14(5):547-52. PubMed ID: 10780717
[TBL] [Abstract][Full Text] [Related]
20. HIV, hepatitis C virus, and hepatitis B virus co-infections among injecting drug users in Tehran, Iran.
Rahimi-Movaghar A; Razaghi EM; Sahimi-Izadian E; Amin-Esmaeili M
Int J Infect Dis; 2010 Jan; 14(1):e28-33. PubMed ID: 19464218
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
